Divisions Faculty Industry Pharmacoengineering and Molecular Pharmaceutics,
Grayson MendenhallNovember 16, 2007
Oriel Therapeutics, an inhaled drug-delivery company cofounded by UNC School of Pharmacy professor Anthony Hickey, PhD, has received a $26.5 million commitment from a group of venture capital firms.
The commitment comes from a group led by New Leaf Partners, a New York venture capital firm. The money will fund the company’s development of drugs that use its patented dry-powder inhaler technology, which was developed at the School.
Based in Research Triangle Park, Oriel was founded in 2001 and holds four U.S. patents. It began as a company that develops inhalers for use with other companies’ medicine, but has since started developing its own drugs.
Media reports about the venture financing:
- News & Observer: Oriel wins $26.5 million pledge to develop drugs
- Triangle Business Journal: Oriel $23M richer; firm brings in new chairman
Latest News
![](https://pharmacy.unc.edu/wp-content/uploads/sites/1043/2024/07/rural-eap-collage-wpv_400x300_center_center.png)
Education, Featured, Featured News, News, Sidebar Featured News, Students
Early Assurance Program inspires students from small towns
![](https://pharmacy.unc.edu/wp-content/uploads/sites/1043/2024/07/rural-scholars-collage-wpv_400x300_center_center.png)
Featured, Featured News, News, Sidebar Featured News, Students
Rural Health Scholars dream to make a difference
![Picture of Lisa Tarantino](https://pharmacy.unc.edu/wp-content/uploads/sites/1043/2019/09/lisa_tarantino_directory_photo-wpv_400x300_center_center.jpg)
Faculty, Featured, Featured News, News, Research, Sidebar Featured News